Porcine hematopoiesis on primate stroma in long-term cultures: enhanced growth with neutralizing tumor necrosis factor-&agr; and tumor growth factor-&bgr; antibodies

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Transplantation

• Publication date

  2002-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00007890-200203150-00011PMID 11907417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cross-species compatibility of intercellular adhesion molecule-1 (CD54) with its ligands.

  2000cited by this paper
• Porcine stem cell engraftment and seeding of murine thymus with class II+ cells in mice expressing porcine cytokines: toward tolerance induction across discordant xenogeneic barriers.

  2000cited by this paper
• Mixed chimerism and tolerance without whole body irradiation in a large animal model.

  2000cited by this paper
• Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

  2000cited by this paper
• Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.

  2000cited by this paper
• Development and analysis of transgenic mice expressing porcine hematopoietic cytokines: a model for achieving durable porcine hematopoietic chimerism across an extensive xenogeneic barrier

  2000cited by this paper
• Mixed chimerism as an approach to transplantation tolerance.

  2000cited by this paper
• Long-term discordant xenogeneic (porcine-to-primate) bone marrow engraftment in a monkey treated with porcine-specific growth factors.

  1999cited by this paper
• Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption.

  1999cited by this paper
• Enhancement of swine progenitor chimerism in mixed swine/human bone marrow cultures with swine cytokines.

  1999cited by this paper
• Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.

  1999cited by this paper
• Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance.

  1999cited by this paper
• Function of porcine adhesion molecules in a human marrow microenvironment.

  1998cited by this paper
• Xenotransplantation: a review of current issues.

  1998cited by this paper
• Role of intrathymic rat class II+ cells in maintaining deletional tolerance in xenogeneic rat-->mouse bone marrow chimeras.

  1998cited by this paper
• Tolerance Induction for Xenotransplantation

  1997cited by this paper
• Xenogeneic bone marrow transplantation: II. Porcine‐specific growth factors enhance porcine bone marrow engraftment in an in vitro primate microenvironment

  1997influential reference
• Xenogeneic bone marrow transplantation: I. Cloning, expression, and species specificity of porcine IL‐3 and granulocyte‐macrophage colony‐stimulating factor

  1997cited by this paper
• Cytokine and chemokine production by CD34+ haemopoietic progenitor cells: detection in single cells

  1997cited by this paper
• Clinical xenotransplantation of solid organs.

  1997cited by this paper
• Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.

  1997cited by this paper
• Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells.

  1996cited by this paper
• The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.

  1996cited by this paper
• Donor‐specific growth factors promote swine hematopoiesis in severe combined immune deficient mice

  1996cited by this paper
• Host marrow has a competitive advantage that limits donor hematopoietic repopulation in mixed xenogeneic chimeras

  1996cited by this paper
• Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha.

  1996cited by this paper
• Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma.

  1996cited by this paper
• TNF-alpha bidirectionally modulates the viability of primitive murine hematopoietic progenitor cells in vitro.

  1996cited by this paper
• TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.

  1996cited by this paper
• Constitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals.

  1995cited by this paper
• Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.

  1995cited by this paper
• Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.

  1995cited by this paper
• Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys

  1995cited by this paper
• Evidence for nonimmune mechanisms in the loss of hematopoietic chimerism in rat→mouse mixed xenogeneic chimeras

  1995cited by this paper
• Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.

  1994cited by this paper
• Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta.

  1994cited by this paper
• Bifunctional effects of tumor necrosis factor alpha (TNF alpha) on the growth of mature and primitive human hematopoietic progenitor cells: involvement of p55 and p75 TNF receptors.

  1994cited by this paper
• Mechanism of tolerance in mixed xenogeneic chimeras prepared with a nonmyeloablative conditioning regimen.

  1994cited by this paper
• Tumor necrosis factor alpha (TNF alpha) downregulates c-kit proto-oncogene product expression in normal and acute myeloid leukemia CD34+ cells via p55 TNF alpha receptors.

  1994cited by this paper
• Engraftment of rat bone marrow and its role in negative selection of murine T cells in mice conditioned with a modified nonmyeloablative regimen

  1994cited by this paper
• The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.

  1994cited by this paper
• TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis.

  1994cited by this paper
• Diffusible factors from the murine cell line M2-10B4 support human in vitro hematopoiesis.

  1994cited by this paper
• TNF-alpha inhibits the further development of committed progenitors while stimulating multipotential progenitors in mouse long-term bone marrow cultures.

  1994cited by this paper
• Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis.

  1994cited by this paper
• THE IMPORTANCE OF NONIMMUNE FACTORS IN RECONSTITUTION BY DISCORDANT XENOGENEIC HEMATOPOIETIC CELLS1,2

  1994cited by this paper
• Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation.

  1993cited by this paper
• HUMORAL TOLERANCE IN XENOGENEIC BMT RECIPIENTS CONDITIONED BY A NONMYELOABLATIVE REGIMEN

  1992cited by this paper
• Effects of tumor necrosis factor-alpha on normal feline hematopoietic progenitor cells.

  1992cited by this paper
• Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis.

  1992cited by this paper
• Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides

  1991cited by this paper
• Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer.

  1991cited by this paper
• Effects of recombinant transforming growth factor-beta 1 on hematologic recovery after treatment of mice with 5-fluorouracil.

  1991cited by this paper
• EVIDENCE THAT RESIDUAL HOST CELLS SURVIVING THE CONDITIONING REGIMEN TO ALLOGENEIC BONE MARROW TRANSPLANTATION INHIBIT DONOR HEMATOPOIESIS IN VITRO—THE ROLE OF TNF-α

  1991cited by this paper
• Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta.

  1990cited by this paper
• Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen

  1990cited by this paper
• Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

  1989cited by this paper
• Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial.

  1988cited by this paper
• Tumor necrosis factor and human hematopoiesis: I. Kinetics and diversity of human bone marrow cell response to recombinant tumor necrosis factor alpha in short-term suspension cultures in vitro.

  1988cited by this paper
• Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro.

  1988cited by this paper
• BONE MARROW TRANSPLANTATION IN MINIATURE SWINE: II Effect of Selective Genetic Differences on Engraftment and Recipient Survival

  1988cited by this paper
• The differential inhibition of hemopoietic growth factor activity by cytotoxins and interferon-gamma.

  1987cited by this paper
• Regulation of haemopoietic stem cell proliferation in long term bone marrow cultures.

  1977cited by this paper
• TRANSPLANTATION IN MINIATURE SWINE: I. Fixation of the Major Histocompatibility Complex

  1976cited by this paper
• Letter: Mass miniature radiography.

  1975cited by this paper
• Organ transplantation between widely disparate species.

  1970cited by this paper
• Organ transplantation between widely disparate species.

  1970cited by this paper
• Brief Definitive Report Tumor Necrosis Factor 0t Is a Potent Synergistic Factor for the Proliferation of Primitive Human Hematopoietic Progenitor Cells and Induces Resistance to Transforming Growth Factor [3 but Not to Interferon ~

  year unknowncited by this paper
• Tumor Necrosis Factor-a Inhibits Stem Cell Factor-induced Proliferation of Human Bone Marrow Progenitor Cells In Vitro Role of p55 and p75 Tumor Necrosis Factor Receptors

  year unknowncited by this paper

• ESC Cardiac Differentiation and Applications

  2011cites this paper
• Human embryonic stem cell-derived cardiomyocytes: inducing strategies.

  2006cites this paper
• Investigations relating to the induction of immunological tolerance through spleen transplantation in miniature swine

  2006influential citation
• Immunological Unresponsiveness in Chimeric Miniature Swine following MHC-Mismatched Spleen Transplantation

  2005cites this paper
• An overview and synopsis of techniques for directing stem cell differentiation in vitro

  2004cites this paper
• Strategies for Directing the Differentiation of Stem Cells Into the Osteogenic Lineage In Vitro

  2004cites this paper
• Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro.

  2004cites this paper
• Methodes permettant d'ameliorer l'acceptation d'une greffe par depletion des cellules souches hematopoietiques

  2003cites this paper